bpc-157 for hashimoto's Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review Regeneration or Risk? A Narrative

The substance appears on the prohibited list under substances without current approval for human therapeutic use

Both animal and human data on dietary methionine and cardiovascular disease risk are too sparse to establish a methionine-excess involvement in atherothrombotic disease

Looney and his team have documented that BM-MSC cells from patients with SLE or lupus model mice are a mix of senescent and healthy cells, and that treatment with FOXO4-DRI can selectively induce apoptosis in senescent cells, allowing the healthy cells to continue to grow and multiply

10.17116/jnevro2019119111133 27 EckertM

8 FDA-approved treatments exist and are fully available